T2DM Clinical Research Study
We are conducting a new clinical study testing a combination of Baxdrostat + Dapagliflozin to see if it can reduce the risk of heart failure and cardiovascular death in people at risk.
Who may qualify?
- Age 40 or older
- Have Type 2 Diabetes
- Have high blood pressure (systolic BP ≥130 mmHg)
- Have a history of cardiovascular disease (such as heart attack, stroke, or artery disease)
- Have at least one additional risk factor for heart failure
Who may not qualify?
- Already diagnosed with heart failure
- Have severe kidney disease (very low kidney function)
- Abnormal blood salts (very high potassium or very low sodium)
- Have Type 1 Diabetes
- Taking certain restricted medications
Why join?
- You may gain early access to new treatments
- Help advance heart disease prevention research
- All study medications and procedures are provided at no cost
Interested?
📞 Contact us at: 847-469-6971